Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alexandria M. Chan
Observed name:
Alexandria Chan
Institutions:
University of Maryland, Baltimore,
University of Utah,
Huntsman Cancer Institute
Observed institutions:
University of Maryland, Baltimore,
University of Utah,
Huntsman Cancer Institute,
University of Maryland, College Park
ORCID:
0000-0001-6196-3036
Observed ORCID:
0000-0001-6196-3036
OpenAlex ID:
A5041090967
Recent applications of covalent chemistries in protein–protein interaction inhibitors
2022
·
Alexandria M. Chan
, Christopher C. Goodis
, et al.
·
RSC Medicinal Chemistry
·
19
Construction of 1H-indazoles from ortho-aminobenzoximes by the Mitsunobu reaction
2019
·
Ivie L. Conlon
, Katie Konsein
, et al.
·
Tetrahedron Letters
·
14
Shifting the paradigm in treating multi-factorial diseases: polypharmacological co-inhibitors of HDAC6
2020
·
Alexandria M. Chan
, Steven Fletcher
·
RSC Medicinal Chemistry
·
13
Histone deacetylase (HDAC) inhibitor specificity determinants are preserved in a class of dual HDAC/non-covalent proteasome inhibitors
2024
·
Alexandria M. Chan
, Ashley Mitchell
, et al.
·
Bioorganic & Medicinal Chemistry
·
10
PDF
The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN–GIL hybrid single-molecule inhibitors
2024
·
Christopher C. Goodis
, Christian Eberly
, et al.
·
European Journal of Medicinal Chemistry
·
8
PDF
First-in-Class Potent, Dual HDAC6/Proteasome Inhibitors Lacking a Hydroxamic Acid Motif: Discovery of Novel Anti-Multiple Myeloma Agents
2025
·
Alexandria M. Chan
, Brandon D. Lowe
, et al.
·
ACS Medicinal Chemistry Letters
·
6
Augmenting the Anti‐Leukemic Activity of the BCL‐2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL‐2/HDAC1 and Dual BCL‐2/HDAC6 Inhibitors
2025
·
Alexandria M. Chan
, Christian Eberly
, et al.
·
Drug Development Research
·
6
PDF
1‐Sulfonylated 1,2,3,4‐tetrahydroquinoline‐6‐carboxylic acids as simple, readily‐accessible MCL‐1 inhibitors
2022
·
Lijia Chen
, Alexandria M. Chan
, et al.
·
Drug Development Research
·
6
Proteolysis Targeting Chimera (PROTAC) Linkerology Enhances the CDK-Degradation Selectivity Profile of a Multi-CDK Inhibitor: Discovery of Potent, Anti-Leukemic CDK9 Degraders
2026
·
Alexandria M. Chan
, Christian Eberly
, et al.
·
ACS Pharmacology & Translational Science
·
1
PDF
Multi-Modal Kinome Profiling Discovers Mesenchymal-Like Polarity Networks that Underly Directed Hepatocellular Carcinoma Cell Migration
2026
·
Thankhoe A. Rants’o
, Kathryn Woods
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Multiomic Analyses Reveal Brainstem Metabolic Changes in a Mouse Model of Dravet Syndrome
2025
·
Ashwini Sri Hari
, Alexandria M. Chan
, et al.
·
Cells
PDF
Show more works
View as search
Works count:
11
Citation count:
83
H-index:
6
I10-index:
4
Year
Topic
Type